Research is being conducted on the genetic and clinical aspects of breast cancers associated with germline BRCA1/2 variants. The studies appear to be exploring various aspects of breast cancer genetics, including the mutational landscape and DNA damage response, in different populations, such as young women, african american women, and elderly patients. The scope of the research seems to be global, with investigations taking place in several regions, including Estonia, South Africa, and African populations.